U.S. Retail REITs Stock News

NYSE:STE
NYSE:STEMedical Equipment

Is It Time To Revisit STERIS (STE) After Its Recent Share Price Pullback

If you are wondering whether STERIS is attractively priced or asking too much at today's levels, the valuation picture is not as straightforward as a simple P/E ratio or quick chart glance might suggest. The stock recently closed at US$214.46, with returns of 0.9% over the last week, a 2.5% decline over 30 days, and a 14.2% decline year to date. This leaves the 1 year return at a 3.7% decline, and the longer-term 3 year and 5 year returns at 16.6% and 13.6% respectively. These mixed returns...
NasdaqGS:PYPL
NasdaqGS:PYPLDiversified Financial

PayPal (PYPL) Q1 Net Margin Strength Tests Bearish Compression Narrative

PayPal Holdings (PYPL) opened 2026 with Q1 revenue of US$8.4b and basic EPS of US$1.22, setting the tone against a backdrop of steady profit generation over the past year. Over the last 12 months, trailing revenue sat at US$33.7b with basic EPS of US$5.38, and earnings growth of 11.3% paired with a net margin of 15% gives investors a results set where profitability and efficiency sit at the center of the story. See our full analysis for PayPal Holdings. With the headline numbers on the table,...
NasdaqGS:BTSG
NasdaqGS:BTSGHealthcare

Is It Too Late To Consider BrightSpring Health Services (BTSG) After A 129% One Year Surge?

Curious whether BrightSpring Health Services at US$52.74 is offering value or just riding hype? This article walks you through what the current price could mean for you as an investor. The stock has returned 9.5% over the past week, 21.2% over the last 30 days, 37.3% year to date and 128.9% over the past year. This naturally raises questions about how much of the story is already reflected in the price. Recent attention around BrightSpring Health Services has centered on its position in the...
NYSE:SQM
NYSE:SQMChemicals

SQM’s Higher Payout and Codelco Lithium Deal Might Change The Case For Investing In Sociedad Química y Minera de Chile (SQM)

In recent months, Sociedad Química y Minera de Chile announced that its board proposed lifting the final dividend payout for 2025 earnings to 50% of net income, subject to shareholder approval, while also finalizing a long-discussed lithium joint venture with state-owned miner Codelco. This combination of a higher prospective cash return and a formalized partnership with Chile’s dominant state miner could materially influence how investors view SQM’s future cash flows and access to lithium...
NYSE:FUN
NYSE:FUNHospitality

Is It Time To Reassess Six Flags Entertainment (FUN) After Its Recent Share Price Rebound?

If you are wondering whether Six Flags Entertainment is attractively priced today or a potential value trap in disguise, this article breaks down what the current share price is really offering you. The stock last closed at US$19.69, with returns of 9.3% over the past week, 10.1% over the past month, 27.1% year to date, and a 45.5% decline over the past year as well as 52.2% and 54.1% declines over the last 3 and 5 years. Recent headlines around Six Flags Entertainment have focused on its...
NYSE:DINO
NYSE:DINOOil and Gas

Assessing HF Sinclair (DINO) Valuation After Surprise Q1 Profit And Renewables Strength

HF Sinclair (DINO) just reported a surprise adjusted profit for the first quarter of 2026, with refining returning to profitability and the renewables segment delivering significant core profit that has drawn fresh attention from investors. See our latest analysis for HF Sinclair. The share price reaction has been mixed around the earnings beat and the recently affirmed dividend and buyback, with a 1 day share price return of a 4.59% decline contrasting with a 51.72% year-to-date share price...
NasdaqGS:TWST
NasdaqGS:TWSTBiotechs

A Look At Twist Bioscience (TWST) Valuation After Strong Q2 Results And Complex Genes Launch

Twist Bioscience (TWST) is back in the spotlight after reporting fiscal second quarter revenue of US$110.72 million, 19% above the prior year, lifting full year guidance and introducing its Complex Genes early access program. See our latest analysis for Twist Bioscience. The earnings beat on revenue, higher full year guidance and Complex Genes launch have coincided with a sharp rerating, with an 83.79% year to date share price return and a very large 3 year total shareholder return, although...
NasdaqGS:STRL
NasdaqGS:STRLConstruction

If AI And Data Centers Keep Surging These Power Grid Stocks Matter

Power markets are being pulled in different directions right now, with rate expectations shifting, construction data soft in several regions, and energy costs closely tied to geopolitics. While this creates plenty of noise for broad equity markets, it also puts a spotlight on the infrastructure that keeps electricity flowing as demand for AI, data centers and electrification keeps building. The Power Grid Technology Stocks screener focuses on companies supplying critical grid hardware and...
NasdaqGS:HUBG
NasdaqGS:HUBGLogistics

A Look At Hub Group (HUBG) Valuation As Rising Fuel Costs Pressure Logistics Margins

Why Fuel Costs Suddenly Matter More for Hub Group Stock A sharp rise in crude oil prices has pushed fuel costs higher, a key expense for logistics providers like Hub Group (HUBG). The stock recently fell 4.1% as investors reassessed margin risk. See our latest analysis for Hub Group. That 4.1% drop sits against a mixed backdrop, with a 16.49% 1 month share price return and a 15.78% decline over 3 months. The 1 year total shareholder return of 38.5% suggests longer term holders have still seen...
NYSE:VZ
NYSE:VZTelecom

Verizon Layoffs Test Cost Control Efforts And Valuation Opportunity

Verizon Communications (NYSE:VZ) is reducing its global workforce by less than 1%, with layoffs concentrated in smaller business units. The company has confirmed that affected employees are being encouraged to apply for other internal roles. Management has stated that AI is not a factor in these job cuts, which follow recent positive operational results. Verizon sits at the center of the US wireless and broadband market, where pressure on costs and capital spending has been a steady theme...
NYSE:BAH
NYSE:BAHProfessional Services

Is Booz Allen Hamilton (BAH) Pricing Reflect Its 36% Share Price Slide And DCF Upside Potential

If you are wondering whether Booz Allen Hamilton Holding stock is offering value at current levels, a useful starting point is to look closely at what the recent share performance and fundamentals are actually showing. The stock last closed at US$76.28, with a 0.2% decline over 7 days, an 8.9% decline over 30 days, a 10.1% decline year to date and a 36.5% decline over the past year. This naturally raises questions about whether the risk and reward are now better balanced. Recent headlines...
NYSE:SMG
NYSE:SMGChemicals

Scotts Miracle-Gro Lawsuit Puts Governance And Valuation Gap In Focus

A federal judge has allowed key investor fraud claims against Scotts Miracle-Gro (NYSE:SMG) to proceed, focusing on alleged misstatements around demand, inventory, and the Hawthorne cannabis unit. The ruling keeps senior management and the company under legal scrutiny, extending an ongoing securities lawsuit rather than dismissing it outright. This development adds a layer of litigation and governance risk that sits alongside existing discussions of earnings, debt, and recovery efforts. For...
NYSE:FBIN
NYSE:FBINBuilding

Assessing Fortune Brands Innovations (FBIN) Valuation After Leadership Upheaval And Pre Q1 2026 Earnings

Recent leadership changes at Fortune Brands Innovations (FBIN), including interim management following activist investor pressure and a canceled CEO appointment, have put the stock in focus ahead of the Q1 2026 earnings report. See our latest analysis for Fortune Brands Innovations. The leadership turmoil and fresh dividend declaration are playing out against a share price that has fallen around 33% over 90 days and a 1 year total shareholder return of about 15% in decline. Shorter term price...
NasdaqGS:ACLS
NasdaqGS:ACLSSemiconductor

Axcelis Technologies (ACLS) Valuation As Q1 2026 Earnings And Margin Concerns Draw Closer Attention

Axcelis Technologies (ACLS) is approaching a closely watched catalyst, with Q1 2026 results and an earnings call scheduled for May 7. Analysts are focusing on profitability pressures and softer revenue expectations. See our latest analysis for Axcelis Technologies. The stock has been on a sharp upswing, with a 1 month share price return of 75.38% and year to date share price return of 98.56%, while the 1 year total shareholder return is 194.42%. This indicates strong momentum into the Q1 2026...
NYSE:LUMN
NYSE:LUMNTelecom

Lumen Technologies (LUMN) Q1 Losses Reinforce Bearish Narrative On Profitability

Lumen Technologies (LUMN) opened Q1 2026 with revenue of US$2.9 billion and a basic EPS loss of US$0.20, alongside net income excluding extra items of a US$200 million loss. Over recent quarters, revenue moved from US$3.3 billion in Q4 2024 to US$3.2 billion in Q1 2025 and US$3.0 billion in Q4 2025. Basic EPS shifted from a profit of US$0.09 in Q4 2024 to losses of US$0.20 in Q1 2025 and US$0.00 in Q4 2025. Taken together, these figures frame Q1 2026 as another period where investors are...
NasdaqGM:SOUN
NasdaqGM:SOUNSoftware

If AI Small Caps Win Big These Three Could Surprise

AI is no longer just a story about mega cap giants. While central banks weigh inflation risks, energy prices swing on geopolitics, and global manufacturing and construction cycles adjust, smaller AI focused companies are quietly building tools in machine learning, automation, and data intelligence that could reshape how businesses work. The AI Small Caps screener is designed to filter this crowded space for early stage potential, so you are not guessing in the dark. Ahead, you will see three...
NasdaqGS:CROX
NasdaqGS:CROXLuxury

A Look At Crocs (CROX) Valuation As Mixed Q1 Results Meet A Raised Full Year Earnings Outlook

Why Crocs stock is back in focus after mixed earnings and guidance Crocs (CROX) just reported first quarter 2026 results showing lower sales and net income year over year, while at the same time tightening second quarter guidance and raising its full year earnings outlook. The combination of softer recent performance and a more confident full year earnings range is giving investors fresh information on how the company sees demand, profitability and its broader footwear portfolio for the rest...
NasdaqGS:FLYW
NasdaqGS:FLYWDiversified Financial

Flywire (FLYW) Q1 EPS Rebound Tests Bullish High‑Growth Narratives

Flywire (FLYW) has kicked off Q1 2026 with total revenue of US$188.1 million, basic EPS of US$0.10, and trailing twelve month EPS of US$0.24, alongside very large year over year earnings growth and a net profit margin reported at 4.5% versus 1% a year ago. Over recent quarters the company has seen revenue move from US$117.6 million in Q4 2024 to US$133.5 million in Q1 2025, US$131.9 million in Q2 2025, US$200.1 million in Q3 2025, US$157.5 million in Q4 2025, and now US$188.1 million in Q1...
NasdaqGS:SRPT
NasdaqGS:SRPTBiotechs

A Look At Sarepta Therapeutics (SRPT) Valuation After Its First Quarter Profit Turnaround

Sarepta Therapeutics (SRPT) stock is reacting to first quarter earnings, where revenue of US$730.8 million compared with US$744.86 million a year earlier, while net income reached US$330.96 million after a prior net loss. See our latest analysis for Sarepta Therapeutics. The latest earnings reversal has arrived after a volatile stretch, with a 90 day share price return of 35.23% and a 1 year total shareholder return decline of 37.28%, suggesting that recent momentum contrasts with longer term...
NYSE:UHS
NYSE:UHSHealthcare

Did Strong Q1 Results, Buybacks and Talkspace Financing Just Shift Universal Health Services' (UHS) Investment Narrative?

In the first quarter of 2026, Universal Health Services reported higher revenue of US$4,495.18 million and net income of US$348.68 million, while also repurchasing 675,000 shares for US$127.3 million and arranging up to US$900 million in new credit facilities partly to fund its Talkspace acquisition. This combination of stronger profitability, continued share repurchases, and additional financing capacity suggests management is actively reshaping the company’s capital structure and...
NYSE:OVV
NYSE:OVVOil and Gas

Is It Too Late To Consider Ovintiv (OVV) After Its 81.8% One Year Rally?

Investors may be wondering whether Ovintiv's share price still offers value after a strong run, or if most of the opportunity is already reflected in the stock. The stock last closed at US$59.90, with returns of 47.9% year to date and 81.8% over the past year. Over the past 7 days the return was a 1.9% decline, and over the past 30 days the return was 0.8%. Recent price moves have drawn attention to how the market is currently weighing Ovintiv's prospects against its risks. Ongoing sector...
NYSE:BKV
NYSE:BKVOil and Gas

Will BKV’s (BKV) Profit Rebound and Low‑Carbon Push Redefine Its Integrated Energy Narrative?

BKV Corporation has reported first-quarter 2026 results, with revenue of US$432.85 million versus US$176.07 million a year earlier and net income of US$44.08 million, compared with a net loss of US$81.98 million, alongside a successful equity raise of US$186.2 million. The company’s return to profitability, combined with progress in its power and carbon capture projects and increased ownership in its BKV-BPP Power joint venture, underpins a broader shift toward integrated low‑carbon energy...
NasdaqGS:KLAC
NasdaqGS:KLACSemiconductor

KLA Stock Split And Dividend Hike Meet Terafab AI Chip Opportunity

KLA (NasdaqGS:KLAC) announced a ten-for-one stock split alongside a 21% increase in its dividend. The company is also positioned to supply inspection and process control equipment to the planned Terafab U.S. chip fabrication project focused on advanced AI processors. These developments are new for KLA and are expected to influence how investors think about the stock and its role in future U.S. chip production. For context, KLA shares recently closed at $1,816.29, with the stock up 17.9%...
NasdaqGS:ADPT
NasdaqGS:ADPTLife Sciences

Adaptive Biotechnologies Q1 Loss Deepens Again And Tests Profitability Improvement Narrative

Adaptive Biotechnologies (ADPT) opened Q1 2026 with revenue of US$70.9 million and a basic EPS loss of US$0.13, alongside a net loss of US$20.0 million. Over recent quarters the company has seen revenue move from US$47.5 million in Q4 2024 to US$52.4 million in Q1 2025, US$58.9 million in Q2 2025, US$94.0 million in Q3 2025 and US$71.7 million in Q4 2025. Quarterly EPS ranged from a loss of US$0.23 in Q4 2024 to a profit of US$0.06 in Q3 2025 and back to a loss of US$0.09 in Q4 2025, putting...